Literature DB >> 16271779

Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure.

Shinji Satoh1, Jun-Ichi Oyama, Nobuhiro Suematsu, Toshiaki Kadokami, Nobuo Shimoyama, Masaaki Okutsu, Takeshi Inoue, Masahiro Sugano, Naoki Makino.   

Abstract

BACKGROUND AND AIMS: Whereas increased circulating proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), play an important role in heart failure, where and how TNF-alpha production is upregulated remains largely unknown. We studied the productivity of TNF-alpha in peripheral lymphocytes and underlying mechanisms in patients with heart failure.
METHODS: Symptomatic NYHA II-IV patients with chronic heart failure with systolic dysfunction (n=39, aged 74+/-11, ejection fraction [EF]<==50%) were compared with asymptomatic NYHA I patients (n=18, aged 72+/-10, EF>50%) and normal subjects (n=15, aged 67+/-11). Lymphocyte subsets (CD3, CD4, and CD8) and intracellular production of TNF-alpha in peripheral leukocytes were quantified by immunofluorescent flow cytometry, and relationships between these parameters and circulating proinflammatory cytokines were analyzed.
RESULTS: Subpopulation of TNF-alpha-producing CD4 was larger in NYHA II-IV patients (23.7% [18.0-28.6]) than in normal subjects (17.1% [6.5-19.5], p<0.05) and was correlated with plasma TNF-alpha levels (r=0.26, p<0.05), EF (r=-0.26, p<0.05), CD4/CD8 ratios (r=0.42, p<0.001), and subpopulation of TNF-alpha-producing monocytes (r=0.47, p<0.0001). Plasma levels of soluble CD14 and interleukin-12 (IL-12) were significantly higher in NYHA II-IV patients than in normal subjects (1971 ng/mL [1740-2375] vs. 1607 ng/mL [1530-1930], p<0.01; and 121 pg/mL [62-230] vs. 62 pg/mL [54-99], p<0.05, respectively), and plasma IL-12 levels were correlated with plasma TNF-alpha levels (r=0.41, p<0.001).
CONCLUSIONS: Increased productivity of TNF-alpha in helper T cells, associated with their dominance over cytotoxic T cells, may partially contribute to an increase in circulating TNF-alpha levels in heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271779     DOI: 10.1016/j.ijcard.2005.08.021

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling.

Authors:  Takeshi Suetomi; Shigeki Miyamoto; Joan Heller Brown
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-23       Impact factor: 4.733

2.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

3.  Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure.

Authors:  Shyam S Bansal; Mohamed Ameen Ismahil; Mehak Goel; Bindiya Patel; Tariq Hamid; Gregg Rokosh; Sumanth D Prabhu
Journal:  Circ Heart Fail       Date:  2017-03       Impact factor: 8.790

4.  Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure.

Authors:  Takashi Fukunaga; Hirofumi Soejima; Atsushi Irie; Koichi Sugamura; Yoko Oe; Tomoko Tanaka; Sunao Kojima; Tomohiro Sakamoto; Michihiro Yoshimura; Yasuharu Nishimura; Hisao Ogawa
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

5.  Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure.

Authors:  V Eskandari; A A Amirzargar; M J Mahmoudi; Z Rahnemoon; F Rahmani; S Sadati; Z Rahmati; F Gorzin; M Hedayat; N Rezaei
Journal:  Ir J Med Sci       Date:  2017-09-09       Impact factor: 1.568

6.  Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes.

Authors:  Melana Yuzefpolskaya; Heidi S Lumish; Azka Javaid; Barbara Cagliostro; Giulio M Mondellini; Bruno Bohn; Austin Sweat; Duygu Onat; Lorenzo Braghieri; Koji Takeda; Yoshifumi Naka; Gabriel T Sayer; Nir Uriel; Justin G Aaron; Emmanuel Montassier; Ryan T Demmer; Paolo C Colombo
Journal:  Eur J Heart Fail       Date:  2021-05-31       Impact factor: 17.349

7.  Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo.

Authors:  Valentina Zanin; Annalisa Marcuzzi; Giulio Kleiner; Elisa Piscianz; Lorenzo Monasta; Serena Zacchigna; Sergio Crovella; Giorgio Zauli
Journal:  J Cardiovasc Transl Res       Date:  2013-12       Impact factor: 4.132

8.  T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure.

Authors:  Carina Gröschel; André Sasse; Charlotte Röhrborn; Sebastian Monecke; Michael Didié; Leslie Elsner; Vanessa Kruse; Gertrude Bunt; Andrew H Lichtman; Karl Toischer; Wolfram-Hubertus Zimmermann; Gerd Hasenfuß; Ralf Dressel
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

Review 9.  Inflammation in Right Ventricular Failure: Does It Matter?

Authors:  Laurence Dewachter; Céline Dewachter
Journal:  Front Physiol       Date:  2018-08-20       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.